文献速递重症综合管理与镇静镇痛

实用性重症监护试验「实用性」的系统评价

Systematic Review of the "Pragmatism" of Pragmatic Critical Care Trials.
PubMed 文献 · Crit Care Explor · 2022-07-22
一句话结论自称为实用性的重症监护随机对照试验中,仅21.4%经PRECIS-2回顾性评分达到「总体实用性」标准。

该系统评价检索MEDLINE和PubMed至2021年11月1日,纳入在标题或摘要中自称为实用性的成人重症监护随机对照试验56项,由培训过的评价者独立双人使用PRECIS-2工具在9个领域按1分(极解释性)至5分(极实用性)评分。仅12项(21.4%)被评为「总体实用性」(5个领域>4分且其余领域为3分),41项至少1个领域需共识讨论,最常见于纳入标准和随访领域。自1995年至2021年总体PRECIS-2评分升高,提示实用性随时间增加;实用性试验更可能豁免知情同意(p=0.05)。作者认为试验设计处于实用性至解释性的连续谱上,需改进设计与报告以确保真实世界适用性。

要点

  • 56项自称为实用性的重症监护RCT中仅12项(21.4%)经PRECIS-2回顾性评分为「总体实用性」。
  • 41项试验至少1个领域评分分歧需共识讨论,最常见于纳入标准和随访领域。
  • 自1995年至2021年,自称为实用性研究的总体PRECIS-2评分升高,提示实用性随时间增加。
  • 实用性试验更可能豁免知情同意(p=0.05)。
  • 作者认为试验设计处于实用性至解释性的连续谱上,需改进重症监护试验的设计与报告以确保真实世界适用性。

适用人群与场景

  • 评估成人重症患者干预措施的随机对照试验,且在标题或摘要中自称为实用性。

诊断标准与关键阈值

  • 使用PRECIS-2工具在9个领域按5分制评分:1分=极解释性,5分=极实用性。
  • 「总体实用性」定义为5个领域评分大于4分且其余领域评分为3分。
  • 评分分歧大于2分时通过共识讨论裁决。

研究设计与关键结果

  • 系统检索MEDLINE和PubMed自建库至2021年11月1日,检索到284项研究,56项符合纳入标准。
  • 41项试验至少1个领域存在需共识讨论的分歧,最常见于纳入标准和随访领域。
  • 12项研究(21.4%)被评为「总体实用性」。
  • 自1995年至2021年,自称为实用性研究的总体PRECIS-2评分升高,提示实用性随时间增加。
  • 实用性试验更可能豁免知情同意(p=0.05)。

证据类型、等级与局限

  • 证据类型:系统评价,使用经验证的PRECIS-2工具评估试验的实用性程度。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,试验设计处于实用性至解释性的连续谱上,不应仅凭标题或摘要中的「实用性」标签判断其真实世界适用性。
  • 作者认为,需改进重症监护试验的设计与报告,以确保其真实世界适用性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: To assess the pragmatism of published critical care randomized controlled trials self-described as pragmatic using a validated tool.

DATA SOURCES: Medical Literature Analysis and Retrieval Online database and PubMed interface from inception to November 1, 2021.

STUDY SELECTION: We performed a systematic search of randomized controlled trials evaluating interventions for critically ill adults that self-identified as pragmatic in title or abstract.

DATA EXTRACTION: Reviewers independently performed study selection and data extraction in duplicate; discrepancies were resolved by consensus. Pragmatism was assessed independently in duplicate by trained reviewers using the Pragmatic-Explanatory Continuum Indicator Summary 2 (PRECIS-2), a validated tool designed to represent how explanatory/pragmatic a trial is on the pragmatic to explanatory continuum. Trials were scored in nine domains on a 5-point continuum (from 1 = very explanatory to 5 = very pragmatic). Discrepancies of greater than 2 points were adjudicated by consensus discussion.

DATA SYNTHESIS: The search resulted in 284 studies; 56 met eligibility criteria. Forty-one of the trials had a discrepancy in at least one domain that required consensus discussion, most commonly in domains of eligibility and follow-up. Twelve studies (21.4%) were scored as "overall pragmatic," defined as score of greater than 4 in five domains provided the scores in the remaining domains were three. The overall PRECIS-2 score of self-identified pragmatic studies increased from 1995 to 2021 suggesting increasing pragmatism over time. Pragmatic trials were more likely to have a waiver of informed consent (p = 0.05).

CONCLUSIONS: The number and pragmatism of self-identified pragmatic trials have increased, particularly in the past decade. However, less than one-quarter of these trials that use the term pragmatic in title or abstract were retrospectively rated as pragmatic. Our results support the concept that trials are designed on a spectrum of pragmatic to explanatory. Advances in the design and reporting of critical care trials are needed to ensure their real-world applicability.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Palakshappa JA, Gibbs KW, Lannan MT, et al. Systematic Review of the "Pragmatism" of Pragmatic Critical Care Trials. Crit Care Explor. 2022. PMID: 35923590. doi:10.1097/CCE.0000000000000738

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。